Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial

Summary: Background: Successful and sustainable models for HIV pre-exposure prophylaxis (PrEP) delivery in public health systems in Africa are needed. We aimed to evaluate the implementation of PrEP delivery integrated in public HIV care clinics in Kenya. Methods: As part of Kenya's national P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elizabeth M Irungu, PhD, Kenneth K Mugwanya, ProfPhD, Nelly R Mugo, ProfMMed, Elizabeth A Bukusi, ProfPhD, Deborah Donnell, ProfPhD, Josephine Odoyo, MPH, Elizabeth Wamoni, BSc, Sue Peacock, MS, Jennifer F Morton, MPH, Kenneth Ngure, ProfPhD, Mary Mugambi, BA, Irene Mukui, MPH, Gabrielle O'Malley, ProfPhD, Jared M Baeten, ProfMD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/a216e07d3dad4619852543994393187d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a216e07d3dad4619852543994393187d
record_format dspace
spelling oai:doaj.org-article:a216e07d3dad4619852543994393187d2021-11-18T04:48:33ZIntegration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial2214-109X10.1016/S2214-109X(21)00391-0https://doaj.org/article/a216e07d3dad4619852543994393187d2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214109X21003910https://doaj.org/toc/2214-109XSummary: Background: Successful and sustainable models for HIV pre-exposure prophylaxis (PrEP) delivery in public health systems in Africa are needed. We aimed to evaluate the implementation of PrEP delivery integrated in public HIV care clinics in Kenya. Methods: As part of Kenya's national PrEP roll-out, we conducted a stepped-wedge cluster-randomised pragmatic trial to catalyse scale-up of PrEP delivery integrated in 25 public HIV care clinics. We selected high-volume clinics in these regions (ie, those with a high number of people living with HIV enrolled in HIV care and treatment). Clinics (each representing a cluster) were stratified by region and randomly assigned to the order in which clinic staff would receive PrEP training and ongoing technical support using numbered opaque balls picked from a bag. There was no masking. PrEP provision was done by clinic staff without additional financial support. Data were abstracted from records of individuals initiating PrEP. The primary outcome was the number of people initiating PrEP per clinic per month comparing intervention to control periods. Other outcomes included PrEP continuation, adherence, and incident HIV infections. This trial is registered with ClinicalTrials.gov, NCT03052010. Findings: After the baseline period, which started in January, 2017, every month two to six HIV care clinics crossed over from control to intervention, until August, 2017, when all clinics were implementing the intervention. Of 4898 individuals initiating PrEP (27 during the control period and 4871 during the intervention period), 2640 (54%) were women, the median age was 31 years (IQR 25–39), and 4092 (84%) reported having a partner living with HIV. The mean monthly number of PrEP initiations per clinic was 0·1 (SD 0·5) before the intervention and 7·5 (2·7) after intervention introduction (rate ratio 23·7, 95% CI 14·2–39·5, p<0·0001). PrEP continuation was 57% at 1 month, 44% at 3 months, and 34% at 6 months, and 12% of those who missed a refill returned later for PrEP re-initiation. Tenofovir diphosphate was detected in 68 (96%) of 71 blood samples collected from a randomly selected subset of participants. Six HIV infections were observed over 2531 person-years of observation (incidence 0·24 cases per 100 person-years), three of which occurred at the first visit after PrEP initiation. Interpretation: We observed high uptake, reasonable continuation with high adherence, frequent PrEP restarts, and low HIV incidence. Integration of PrEP services within public HIV care clinics in Africa is feasible. Funding: National Institute of Mental Health and Bill &amp; Melinda Gates Foundation.Elizabeth M Irungu, PhDKenneth K Mugwanya, ProfPhDNelly R Mugo, ProfMMedElizabeth A Bukusi, ProfPhDDeborah Donnell, ProfPhDJosephine Odoyo, MPHElizabeth Wamoni, BScSue Peacock, MSJennifer F Morton, MPHKenneth Ngure, ProfPhDMary Mugambi, BAIrene Mukui, MPHGabrielle O'Malley, ProfPhDJared M Baeten, ProfMDElsevierarticlePublic aspects of medicineRA1-1270ENThe Lancet Global Health, Vol 9, Iss 12, Pp e1730-e1739 (2021)
institution DOAJ
collection DOAJ
language EN
topic Public aspects of medicine
RA1-1270
spellingShingle Public aspects of medicine
RA1-1270
Elizabeth M Irungu, PhD
Kenneth K Mugwanya, ProfPhD
Nelly R Mugo, ProfMMed
Elizabeth A Bukusi, ProfPhD
Deborah Donnell, ProfPhD
Josephine Odoyo, MPH
Elizabeth Wamoni, BSc
Sue Peacock, MS
Jennifer F Morton, MPH
Kenneth Ngure, ProfPhD
Mary Mugambi, BA
Irene Mukui, MPH
Gabrielle O'Malley, ProfPhD
Jared M Baeten, ProfMD
Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
description Summary: Background: Successful and sustainable models for HIV pre-exposure prophylaxis (PrEP) delivery in public health systems in Africa are needed. We aimed to evaluate the implementation of PrEP delivery integrated in public HIV care clinics in Kenya. Methods: As part of Kenya's national PrEP roll-out, we conducted a stepped-wedge cluster-randomised pragmatic trial to catalyse scale-up of PrEP delivery integrated in 25 public HIV care clinics. We selected high-volume clinics in these regions (ie, those with a high number of people living with HIV enrolled in HIV care and treatment). Clinics (each representing a cluster) were stratified by region and randomly assigned to the order in which clinic staff would receive PrEP training and ongoing technical support using numbered opaque balls picked from a bag. There was no masking. PrEP provision was done by clinic staff without additional financial support. Data were abstracted from records of individuals initiating PrEP. The primary outcome was the number of people initiating PrEP per clinic per month comparing intervention to control periods. Other outcomes included PrEP continuation, adherence, and incident HIV infections. This trial is registered with ClinicalTrials.gov, NCT03052010. Findings: After the baseline period, which started in January, 2017, every month two to six HIV care clinics crossed over from control to intervention, until August, 2017, when all clinics were implementing the intervention. Of 4898 individuals initiating PrEP (27 during the control period and 4871 during the intervention period), 2640 (54%) were women, the median age was 31 years (IQR 25–39), and 4092 (84%) reported having a partner living with HIV. The mean monthly number of PrEP initiations per clinic was 0·1 (SD 0·5) before the intervention and 7·5 (2·7) after intervention introduction (rate ratio 23·7, 95% CI 14·2–39·5, p<0·0001). PrEP continuation was 57% at 1 month, 44% at 3 months, and 34% at 6 months, and 12% of those who missed a refill returned later for PrEP re-initiation. Tenofovir diphosphate was detected in 68 (96%) of 71 blood samples collected from a randomly selected subset of participants. Six HIV infections were observed over 2531 person-years of observation (incidence 0·24 cases per 100 person-years), three of which occurred at the first visit after PrEP initiation. Interpretation: We observed high uptake, reasonable continuation with high adherence, frequent PrEP restarts, and low HIV incidence. Integration of PrEP services within public HIV care clinics in Africa is feasible. Funding: National Institute of Mental Health and Bill &amp; Melinda Gates Foundation.
format article
author Elizabeth M Irungu, PhD
Kenneth K Mugwanya, ProfPhD
Nelly R Mugo, ProfMMed
Elizabeth A Bukusi, ProfPhD
Deborah Donnell, ProfPhD
Josephine Odoyo, MPH
Elizabeth Wamoni, BSc
Sue Peacock, MS
Jennifer F Morton, MPH
Kenneth Ngure, ProfPhD
Mary Mugambi, BA
Irene Mukui, MPH
Gabrielle O'Malley, ProfPhD
Jared M Baeten, ProfMD
author_facet Elizabeth M Irungu, PhD
Kenneth K Mugwanya, ProfPhD
Nelly R Mugo, ProfMMed
Elizabeth A Bukusi, ProfPhD
Deborah Donnell, ProfPhD
Josephine Odoyo, MPH
Elizabeth Wamoni, BSc
Sue Peacock, MS
Jennifer F Morton, MPH
Kenneth Ngure, ProfPhD
Mary Mugambi, BA
Irene Mukui, MPH
Gabrielle O'Malley, ProfPhD
Jared M Baeten, ProfMD
author_sort Elizabeth M Irungu, PhD
title Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
title_short Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
title_full Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
title_fullStr Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
title_full_unstemmed Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial
title_sort integration of pre-exposure prophylaxis services into public hiv care clinics in kenya: a pragmatic stepped-wedge randomised trial
publisher Elsevier
publishDate 2021
url https://doaj.org/article/a216e07d3dad4619852543994393187d
work_keys_str_mv AT elizabethmirunguphd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT kennethkmugwanyaprofphd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT nellyrmugoprofmmed integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT elizabethabukusiprofphd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT deborahdonnellprofphd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT josephineodoyomph integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT elizabethwamonibsc integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT suepeacockms integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT jenniferfmortonmph integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT kennethngureprofphd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT marymugambiba integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT irenemukuimph integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT gabrielleomalleyprofphd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
AT jaredmbaetenprofmd integrationofpreexposureprophylaxisservicesintopublichivcareclinicsinkenyaapragmaticsteppedwedgerandomisedtrial
_version_ 1718425057970094080